MedTrace Logo

Study of Preoperative Boost Radiotherapy

NCT02482389 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-04-14

Study results available
· View outcomes & findings →

Summary

This protocol seeks to utilize a novel method of tumor bed boost delivery and to better understand breast cancer radiation response through the analysis of pre-and post-radiation breast tumor samples.

Conditions

Interventions

RADIATION

Single fraction of 7 Gy

All subjects will receive a single 7 Gy fraction of radiotherapy to the intact tumor prior to surgery.

Sponsors & Collaborators

  • Gateway for Cancer Research

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Rachel Blitzblau, MD PhD · Duke Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-08
Primary Completion
2021-06-25
Completion
2021-06-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482389 on ClinicalTrials.gov